PFE · Pfizer GP
last $28.290-0.49%volume $10.19Mmarket cap n/afeed alpacaas of 2026-09-25 15:30
one year · daily closes52-week high $29.02552-week low $23.6001m -0.5%3m +20.0%1y +18.1%
FA · financials · PFIZER INC from the company's own filingsEDGAR ↗
| quarter ending | 2026-06-28 | 2026-03-29 | 2025-12-31 | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-12-31 | 2024-09-29 |
|---|---|---|---|---|---|---|---|---|
| revenue | $15.03B | $14.45B | $17.56B | $16.65B | $14.65B | $13.71B | $17.76B | $17.70B |
| net income | $-248.00M | $2.69B | $-1.65B | $3.54B | $2.91B | $2.97B | $410.00M | $4.46B |
| EPS (diluted) | -0.04 | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 | 0.07 | 0.78 |
| operating cash flow | $835.00M | $2.62B | $5.35B | $4.60B | $-582.00M | $2.33B | $6.72B | $6.71B |
total assets $201.13B (2026-06-28)cash $976.00M (2026-06-28)long term debt $60.49B (2026-06-28)equity $85.19B (2026-06-28)shares outstanding 5,699,673,589 (2026-07-29)
quarterly figures as filed (10-Q / 10-K); where a company reports year-to-date, the quarter is the difference. No estimates.
news · PFEmore →
no matching headlines in the last hours